These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 2821477

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
    Vesikari T, Rautanen T, Varis T, Beards GM, Kapikian AZ.
    Am J Dis Child; 1990 Mar; 144(3):285-9. PubMed ID: 2154925
    [Abstract] [Full Text] [Related]

  • 4. Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants.
    Vesikari T, Karvonen A, Korhonen T, Espo M, Lebacq E, Forster J, Zepp F, Delem A, De Vos B.
    Vaccine; 2004 Jul 29; 22(21-22):2836-42. PubMed ID: 15246619
    [Abstract] [Full Text] [Related]

  • 5. Lack of shedding of the RIX4414 live attenuated rotavirus vaccine administered to adult volunteers.
    Zibrik L, Dove W, McArdle F, Rustom R, Hart CA, Jackson MJ.
    Arch Virol; 2007 Jul 29; 152(10):1951-4. PubMed ID: 17623269
    [Abstract] [Full Text] [Related]

  • 6. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
    Ruiz-Palacios GM, Guerrero ML, Bautista-Márquez A, Ortega-Gallegos H, Tuz-Dzib F, Reyes-González L, Rosales-Pedraza G, Martínez-López J, Castañón-Acosta E, Cervantes Y, Costa-Clemens S, DeVos B.
    Pediatrics; 2007 Aug 29; 120(2):e253-61. PubMed ID: 17606534
    [Abstract] [Full Text] [Related]

  • 7. A review of the current status of enteric vaccines.
    Levine MM, Noriega F.
    P N G Med J; 1995 Dec 29; 38(4):325-31. PubMed ID: 9522876
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants.
    Clark HF, Bernstein DI, Dennehy PH, Offit P, Pichichero M, Treanor J, Ward RL, Krah DL, Shaw A, Dallas MJ, Laura D, Eiden JJ, Ivanoff N, Kaplan KM, Heaton P.
    J Pediatr; 2004 Feb 29; 144(2):184-90. PubMed ID: 14760258
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.
    Linhares AC, Gabbay YB, Mascarenhas JD, de Freitas RB, Oliveira CS, Bellesi N, Monteiro TA, Lins-Lainson Z, Ramos FL, Valente SA.
    Bull World Health Organ; 1996 Feb 29; 74(5):491-500. PubMed ID: 9002329
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical and immunological studies of rotavirus vaccines.
    Vesikari T.
    Southeast Asian J Trop Med Public Health; 1988 Sep 29; 19(3):437-47. PubMed ID: 2851185
    [Abstract] [Full Text] [Related]

  • 16. The present status of rotavirus vaccine development.
    Bishop R.
    Southeast Asian J Trop Med Public Health; 1988 Sep 29; 19(3):429-35. PubMed ID: 2851184
    [Abstract] [Full Text] [Related]

  • 17. Epidemiologic background for the need of rotavirus vaccine in Finland. Preliminary experience of RIT 4237 strain of live attenuated rotavirus vaccine in adults.
    Vesikari T, Mäki M, Isolauri E.
    Dev Biol Stand; 1983 Sep 29; 53():229-36. PubMed ID: 6307778
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial.
    Bhandari N, Sharma P, Taneja S, Kumar T, Rongsen-Chandola T, Appaiahgari MB, Mishra A, Singh S, Vrati S, Rotavirus Vaccine Development Group.
    J Infect Dis; 2009 Aug 01; 200(3):421-9. PubMed ID: 19545211
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.